Could a light cap lift bipolar depression? new trial begins
NCT ID NCT07510646
First seen Apr 11, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This pilot study tests whether a wearable light device (Vielight RX Gamma) aimed at the brain can safely improve symptoms of bipolar depression. Forty adults with bipolar depression will receive either active or sham treatment in clinic five days a week for six weeks. Researchers will measure changes in depression severity, thinking skills, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER (BD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Providence Care Hospital
Kingston, Ontario, K7L 4X3, Canada
Conditions
Explore the condition pages connected to this study.